
Aquinnova Pharmaceuticals Private Limited
Pharmaceutical company specializing in manufacturing, marketing, and distribution of medical products.
Pharmaceutical company specializing in manufacturing, marketing, and distribution of medical products.
Aquinnova Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 2018 (Seven years and two months 20 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.78 M.
Mahendra Nokhwal, Jyoti Pathak, and Kuldeep Gupta serve as directors at the Company.
Indore, Madhya Pradesh, India
+91-XXXXXXXXXX
U24290MP2018PTC045407
045407
Private Limited Indian Non-Government Company
27 Mar 2018
30 Sep 2024
31 Mar 2024
Unlisted
Roc Gwalior
Aquinnova Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Fitness Supplements, Multivitamin Tablets & Capsules, Mineral Supplement, Nutritional Supplements, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Protein Powder.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kuldeep Gupta ![]() | Director | 27-Mar-2018 | Current |
Mahendra Nokhwal ![]() | Director | 27-Mar-2018 | Current |
Jyoti Pathak ![]() | Director | 27-Mar-2018 | Current |
Aquinnova Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.26% increase. The company also saw a substantial improvement in profitability, with a 93.55% increase in profit. The company's net worth Soared by an impressive increase of 71.89%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Aquinnova Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹1.78 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
14 Aug 2020 | Others | ₹0.61 M | Open |
27 Jan 2020 | Others | ₹0.55 M | Open |
16 Jan 2020 | Others | ₹0.62 M | Open |
Aquinnova Pharmaceuticals has a workforce of 26 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aquinnova Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aquinnova Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aquinnova Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Aquinnova Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
A charge with Others amounted to Rs. 0.61 M with Charge ID 100376134 was registered on 14 Aug 2020.
A charge with Others amounted to Rs. 0.55 M with Charge ID 100376138 was registered on 27 Jan 2020.
A charge with Others amounted to Rs. 0.62 M with Charge ID 100375949 was registered on 16 Jan 2020.
Mahendra Nokhwal was appointed as a Director was appointed as a Director on 27 Mar 2018 & has been associated with this company since 7 years 2 months .
Aquinnova Pharmaceuticals Private Limited was incorporated on 27 Mar 2018.
The authorized share capital of Aquinnova Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Aquinnova Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Aquinnova Pharmaceuticals Private Limited is S.No.116 President Tower, 6/2 South Tukoganj India, Indore, Madhya Pradesh, 452001.
The corporate identification number (CIN) of Aquinnova Pharmaceuticals Private Limited is U24290MP2018PTC045407 and the company number is 045407 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Aquinnova Pharmaceuticals Private Limited has risen by 46.26%.
As Per 2022 financial reports, 26 employees are currently employed by Aquinnova Pharmaceuticals Private Limited.
The financial reports for the fiscal year 2022 indicates that The net worth of Aquinnova Pharmaceuticals Private Limited has experienced an upsurge of 71.89%.
As per the financial statements for fiscal Year 2022, The total open charges for Aquinnova Pharmaceuticals Private Limited amount to ₹ 1.78 M.
The most recent Balance Sheet for Aquinnova Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.